JMP Securities reiterated its Market Outperform rating on Protagonist Therapeutics (NASDAQ:PTGX) with a steady price target ...

JMP Securities updated its outlook on Affirm Holdings Inc. (NASDAQ: NASDAQ:AFRM), increasing the price target to $85 from the ...

JMP Securities raised the firm’s price target on Cloudflare (NET) to $180 from $135 and keeps an Outperform rating on the shares. Cloudflare ...

JMP Securities analyst Reni Benjamin maintained a Buy rating on Blueprint Medicines (BPMC – Research Report) today and set a price target of ...

Mr. Cooper Group Inc. (NASDAQ:COOP – Get Free Report) was the target of unusually large options trading on Wednesday. Traders acquired 10,613 call options on the stock. This is an increase of ...

Covering some solid dividend stocks for JMP, analyst Aaron Hecht sees a reason to bet on higher value in the coming year. He notes that multiple tailwinds are coming together, and will likely lead ...

PJT Partners (NYSE:PJT – Get Free Report) had its price objective boosted by equities researchers at Keefe, Bruyette & Woods from $152.00 to $177.00 in a report issued on Wednesday,Benzinga reports.

JMP Securities raised the price targets on Cloudflare (NET) and CyberArk Software (CYBR), while highlighting an industry ...

JMP Securities analyst Constantine Davides raised the firm’s price target on Option Care Health (OPCH) to $35 from $30 and ...

Pharvaris (PHVS) is climbing 3% after investment bank JMP Securities raised its price target on the shares to $55, based on ...

Google parent Alphabet Inc. has been downgraded to market perform from market outperform by JMP Securities, with the analyst firm highlighting the potential impact of the company’s antitrust battle.